Ayurcann signs supply agreement to have products sold on CannMart and Patients Choice platforms.
Ayurcann signs supply agreement to have products sold on CannMart and Patients Choice platforms. Ayurcann Holdings (CSE: AYUR) CEO Igal Sudman joined Steve Darling from Proactive to shares news the company has signed a two supply deals with medical cannabis product suppliers, CannMart Inc and Patient Choice to sell branded products directly to medical patient consumers. Sudman shared with Proactive consumers will soon be able to choose Ayurcann products like XPLOR Pure CBD 1000 Tincture, Fuego ...
Source: proactiveinvestors.com